Kidney Cancer Biomarker Predicts Disease Risk and Survival

Validated diagnostic markers are key to the early detection and treatment of cancer. Moreover, if these biomarkers can be readily extracted and detected in bodily fluids, a simple, clinical diagnostic test can be developed that would be of extreme value to patients and physicians. For kidney cancer, investigators at Brigham and Women's Hospital (BWH) and Beth-Israel Deaconess Medical Center believe they have found such a biomarker. In a new study, the researchers showed that Kidney-injury-molecu